Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)

计划入组 70 人 · 首次发布于 2014 年 11 月 7 日

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

计划入组 270 人 · 首次发布于 2025 年 10 月 7 日

ARX-111 (Ambrx)

Peginterferon Lambda( Ambrx)

Long acting relaxin(Ambrx)

AMBRX, INC.

United States

J&J Acquires Ambrx for $2B to Expand Antibody-Drug Conjugate Portfolio in Oncology

Robust Clinical Trial Pipeline Fuels Hope for Renal and Breast Cancer Advances

Breast Cancer R&D Pipeline Expands to Over 300 Drugs with Novel PROTACs, ADCs, and CDK Inhibitors